Kenya’s national accounts were re-based in 2014 resulting in an upward revision of Kenya’s GDP per capita and reclassification of the country to a lower middle-income status. With this reclassification, Kenya will progressively become ineligible for international support towards its vertical programmes. The country needs to plan for the transition of its vertical programs away from international support and onto sustainable domestic financing mechanisms.
E&K provided the following:
−Led research and analytical work on sustainable financing for vertical programs (Immunization; Malaria; Family Planning; HIV/AIDS; and Tuberculosis) in Kenya
−Supported the Ministry of Health and Treasury to appraise alternative domestic financing mechanisms
−Currently conducting deep dive analytical work and developing a blue print and roadmap on how the Ministry of Health – Kenya can successfully graduate its vertical health programs from donor support and onto sustainable financing mechanisms
- E&K Consulting Firm draws lessons from its experience in advising a US$ 20 Billion merger and acquisition in the global pharmaceutical industry and publishes a white paper on the global pharma industry and its implications on Africa